[An increase in the hydro-osmotic effect of vasopressin during neomycin suppression of phosphatidylinositol 4,5-diphosphate hydrolysis].
Parnova
R G
RG
Firsov
D L
DL
D000818:Animals; D002463:Cell Membrane Permeability / Q000187:drug effects / Q000502:physiology; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006868:Hydrolysis / Q000187:drug effects; D066298:In Vitro Techniques; D009355:Neomycin / Q000494:pharmacology*; D009995:Osmosis / Q000187:drug effects; D019269:Phosphatidylinositol 4,5-Diphosphate; D010716:Phosphatidylinositols / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D054801:Phosphoinositide Phospholipase C; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011896:Rana temporaria; D001743:Urinary Bladder / Q000187:drug effects / Q000378:metabolism; D014667:Vasopressins / Q000494:pharmacology*
D019269:Phosphatidylinositol 4,5-Diphosphate; D010716:Phosphatidylinositols; D010726:Phosphodiesterase Inhibitors; D014667:Vasopressins; D010727:Phosphoric Diester Hydrolases; D054801:Phosphoinositide Phospholipase C; D009355:Neomycin
Uvelichenie gidroosmoticheskogo éffekta vazopressina pri ugnetenii neomitsinom gidroliza fosfatidilinozit-4,5-difosfata.